Abstract
To evaluate the effects of Toll-like receptor 4 (TLR4) signaling on the activation of the transcription factor activator protein-1 (AP-1) in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease (PD). The following groups were evaluated: normal saline (NS)-treated WT mice, NS-treated TLR4-knockout (KO) mice, MPTP-treated WT mice, and MPTP-treated TLR4-KO mice. After establishing the mouse model, behavioral changes were evaluated. AP-1 expression was detected by RT-PCR, Western blotting, immunohistochemistry and immunofluorescence staining. Compared to MPTP-treated WT mice, significantly reduced dyskinesia was observed in MPTP-treated TLR4-KO mice. AP-1 mRNA and protein levels were significantly up-regulated in the substantia nigras (SNs) of MPTP-treated WT mice relative to NS-treated mice (P<0.01); these levels were significantly reduced in MPTP-treated TLR4-KO mice relative to MPTP-treated WT mice (P<0.01). Immunohistochemical staining demonstrated that AP-1 was distributed throughout the SN in MPTP-treated mice, and immunofluorescence further showed that AP-1 was expressed in TH-positive neuronal cells and GFAP-positive astrocytes. In addition, immunofluorescence revealed that AP-1 e...Continue Reading
References
Aug 1, 1994·Annals of Neurology·A KastnerY Agid
Apr 15, 1994·European Journal of Biochemistry·D GalterW Dröge
Apr 1, 1997·Current Opinion in Cell Biology·M KarinE Zandi
Apr 25, 1997·Journal of Neuroscience Methods·K MatsuuraN Ogawa
Dec 16, 1998·Science·A PoltorakB Beutler
Jun 13, 2001·Oncogene·F Mechta-GrigoriouM Yaniv
Jun 13, 2001·Oncogene·W JochumE F Wagner
Aug 3, 2001·Gene·T Hai, M G Hartman
Nov 9, 2001·The International Journal of Neuroscience·R W RodriguesG Chadi
Jun 5, 2002·Neuroscience·V RibanA Depaulis
Aug 3, 2002·Journal of Neurochemistry·T BreidertE C Hirsch
May 11, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Rajappa S KenchappaVijayalakshmi Ravindranath
Nov 27, 2004·Journal of Cell Science·Jochen HessMarina Schorpp-Kistner
Nov 22, 2005·Free Radical Biology & Medicine·Shuling WuReinhard Gessner
May 24, 2006·Progress in Neurobiology·Gennadij Raivich, Axel Behrens
Jun 9, 2006·In Vitro Cellular & Developmental Biology. Animal·Shubhashish SarkarGovindarajan T Ramesh
Nov 30, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Patrick L McGeer, Edith G McGeer
Mar 20, 2009·Lancet Neurology·Etienne C Hirsch, Stéphane Hunot
Nov 3, 2009·Journal of Neurochemistry·Amanda J MeadeNeville W Knuckey
Apr 10, 2012·CNS & Neurological Disorders Drug Targets·Yanzhen ZhuYanjun Zeng
Jul 4, 2012·Experimental Neurology·Melanie B WatsonMarie-Françoise Chesselet
Mar 7, 2013·Scientific Reports·Carmen NoelkerAndreas Hartmann
Mar 7, 2013·Nature Communications·Changyoun KimSeung-Jae Lee
Jan 2, 2014·Journal of Neural Transmission·Giulia AmbrosiFabio Blandini
Feb 18, 2014·Journal of Neuroimmunology·Teresa TrottaMaria Antonietta Panaro
Jun 3, 2014·Journal of Neuroinflammation·Carmen NoelkerAndreas Hartmann
May 30, 2015·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Fa-Xiang WangHui Yang
Citations
Jan 22, 2017·Neurochemical Research·Carmela ConteLaura Corte
Feb 27, 2019·Current Drug Targets·Arunaksharan Narayanankutty
Aug 16, 2018·BMC Complementary and Alternative Medicine·Ming-Yii HuangChia-Yang Li
Mar 10, 2021·Journal of Molecular Neuroscience : MN·Gagandeep KaurSimona Bungau
Jul 3, 2021·Biomolecules·Antía CustodiaAlberto Ouro
Aug 5, 2021·Neurochemical Research·Zhe ZhongMin Ye